Hamburger J I
J Clin Endocrinol Metab. 1994 Aug;79(2):335-9. doi: 10.1210/jcem.79.2.8045944.
FNB can be as good as you make it, and vice versa. Most worrisome to physicians and patients is the false negative diagnosis. The stringent criterion that I have advised for adequate sampling to exclude cancer can reduce the potential for false negative diagnoses to about 1%. Specific FNB tissue diagnoses provide the best guidelines for management decisions on when to operate and what operation to perform. However, each institution must generate its own FNB statistics. Management of follicular neoplasms requires integration of FNB findings with clinical features that relate to the probability of cancer and the risks thereof as well as the risks of operation. When FNB provides inadequate numbers of benign-appearing cells to exclude malignancy, unless there are compelling clinical features suggesting cancer, it may be suitable to observe as long as the course and subsequent FNBs fail to suggest cancer.
细针穿刺活检(FNB)的效果好坏取决于你的操作水平,反之亦然。对医生和患者来说,最令人担忧的是假阴性诊断。我建议采用严格的标准进行充分取样以排除癌症,这样可将假阴性诊断的可能性降低至约1%。特定的FNB组织诊断为何时进行手术以及进行何种手术的管理决策提供了最佳指导方针。然而,每个机构都必须生成自己的FNB统计数据。滤泡性肿瘤的管理需要将FNB结果与临床特征相结合,这些临床特征与癌症的可能性及其风险以及手术风险相关。当FNB提供的看似良性的细胞数量不足以排除恶性肿瘤时,除非有令人信服的临床特征提示癌症,否则只要病程和后续的FNB未提示癌症,观察可能是合适的。